Clinical Trial

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

Name: IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors — clinical trial record (NCT07508761)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Phase 1/2 Study for IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-30

Trial Details

NCT Number	NCT07508761
Lead Sponsor	Nanjing Immunophage Biotech Co., Ltd
Conditions	Advanced Solid Tumor
Enrollment	52 participants
Start Date	2026-06-16
Primary Completion	2028-12-30 (estimated)
Study Completion	2029-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-29